Jaeckel E, Lehner F
Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover, Hannover.
Internist (Berl). 2009 May;50(5):536-49. doi: 10.1007/s00108-008-2272-z.
Pancreas transplantation is a successful and effective procedure resulting in tight glucose control. Due to the postoperative morbidity and the need for immunosuppression pancreas transplantation should be considered in patients with type I diabetes at the time of kidney transplantation. Besides this pancreas transplantation alone can be taken into consideration for patients with very poor metabolic control and quality of life despite optimal medical treatment. Recently, islet transplantation became a less invasive alternative to pancreas transplantation. Due to the lack of long-term follow-up and due to the need of multiple donor grafts for one recipient, islet transplantation should be performed under experimental settings in experienced centers. New developments in protecting transplanted islets and in the induction of donor-specific tolerance could increase the indication to perform the procedure. Therefore alternative sources of beta-cells have to be identified.
胰腺移植是一种成功且有效的手术,可实现严格的血糖控制。由于术后发病率以及免疫抑制的需求,对于I型糖尿病患者,在进行肾移植时应考虑胰腺移植。除此之外,对于尽管接受了最佳药物治疗但代谢控制和生活质量仍非常差的患者,可单独考虑胰腺移植。最近,胰岛移植成为了一种侵入性较小的胰腺移植替代方法。由于缺乏长期随访以及一名受者需要多个供体移植物,胰岛移植应在经验丰富的中心的实验环境下进行。保护移植胰岛和诱导供体特异性耐受方面的新进展可能会增加该手术的适应症。因此,必须确定β细胞的替代来源。